Sfoglia per Autore
Total triterpenic fraction of Centella asiatica in chronic venous insufficiency and in high-perfusion microangiopathy.
2001-01-01 Incandela, L; Cesarone, Mr; Cacchio, Marisa Adriana; De Sanctis, Mt; Santavenere, C; D'Auro, Mg; Bucci, Marco; Belcaro, Giovanni
Flight microangiopathy in medium- to long-distance flights: prevention of edema and microcirculation alterations with total triterpenic fraction of Centella asiatica.
2001-01-01 Cesarone, Mr; Incandela, L; De Sanctis, Mt; Belcaro, Giovanni; Geroulakos, G; Griffin, M; Lennox, A; Di Renzo, Ad; Cacchio, Marisa Adriana; Bucci, Marco
Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of Centella Asiatica: a clinical prospective randomized trial with a microcirculatory model.
2001-01-01 Cesarone, Mr; Incandela, L; De Sanctis, Mt; Belcaro, Giovanni; Bavera, P; Bucci, Marco; Ippolito, E.
Microcirculatory effects of total triterpenic fraction of Centella asiatica in chronic venous hypertension: measurement by laser Doppler, TcPO2-CO2, and leg volumetry.
2001-01-01 Cesarone, Mr; Belcaro, G; Rulo, A; Griffin, M; Ricci, A; Ippolito, E; DE SANCTIS, Mt; Incandela, L; Bavera, P; Cacchio, M; Bucci, Marco
Total triterpenic fraction of Centella asiatica in the treatment of venous hypertension: a clinical, prospective, randomized trial using a combined microcirculatory model.
2001-01-01 Incandela, L; Belcaro, Giovanni; De Sanctis, Mt; Cesarone, Mr; Griffin, M; Ippolito, E; Bucci, Marco; Cacchio, Marisa Adriana
Treatment of Diabetic Microangiopathy and Edema with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled Randomized Study.
2001-01-01 Incandela, L; Belcaro, G; Cesarone, Mr; De Sanctis, Mt; Nargi, E; Patricelli, P; Bucci, Marco
Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10 year follow-up study (the CAFES-CAVE Study).
2001-01-01 Belcaro, G; Nicolaides, An; Ramaswami, G; Cesarone, Mr; DE SANCTIS, Mt; Incandela, L; Ferrari, Pg; Geroulakos, G; Barsotti, A; Griffin, M; Dhanjil, S; Bucci, Marco
HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial.
2002-01-01 Incandela, L; Belcaro, G; Renton, S; Desanctis, Mt; Cesarone, Mr; Bavera, P; Ippolito, E; Bucci, Marco; Griffin, M; Geroulakos, G; Dugall, M; Golden, G; Acerbi, G.
Treatment of intermittent claudication with pentoxifylline: A 12-month, randomized trial: Walking distance and microcirculation
2002-01-01 De Sanctis, M. T.; Cesarone, M. R.; Belcaro, Giovanni; Nicolaides, A. N.; Griffin, M.; Incandela, L.; Bucci, Marco; Geroulakos, G.; Ramaswami, G.; Vasdekis, S.; Agus, G.; Bavera, P.; Ippolito, E.
Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial.
2002-01-01 DE SANCTIS, Mt; Cesarone, Mr; Belcaro, G; Nicolaides, An; Griffin, M; Incandela, L; Bucci, Marco; Geroulakos, G; Ramaswami, G; Vasdekis, S; Agus, G; Bavera, P; Ippolito, E.
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty.
2003-01-01 Cipollone, Francesco; Ferri, C; Desideri, G; Paloscia, L; Materazzo, G; Mascellanti, M; Fazia, Maria Luigia; Iezzi, Annalisa; Cuccurullo, Chiara; Pini, Barbara; Bucci, Marco; Santucci, A; Cuccurullo, Franco; Mezzetti, Andrea
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteases activity
2004-01-01 Cipollone, Francesco; Fazia, Maria Luigia; Iezzi, Annalisa; Pini, Barbara; Cuccurullo, Chiara; Zucchelli, Mirco; DE CESARE, Domenico; Ucchino, Sante; Spigonardo, F; DE LUCA, MARIA LUIGIA; Muraro, Raffaella; Bei, R; Bucci, Marco; Cuccurullo, Franco; Mezzetti, Andrea
Association between 5-lipoxygenase expression and plaque instability in humans.
2005-01-01 Cipollone, Francesco; Mezzetti, Andrea; Fazia, Maria Luigia; Cuccurullo, Chiara; Chiarelli, Francesco; Ucchino, Sante; Spigonardo, F; Bucci, Marco; Cuccurullo, Franco; Prescott, Sm; Stafforini, Dm; Iezzi, Annalisa
Reduced TIA-1 expression in vulnerable atherosclerotic plaques as a basis of cyclooxygenase-2-dependent plaque instability in humans.
2005-01-01 Cipollone, Francesco; Fazia, Maria Luigia; A., Iezzi; Cuccurullo, Chiara; Ucchino, Sante; F., Spigonardo; Bucci, Marco; Mezzetti, Andrea
OVEREXPRESSION OF TOLL LIKE RECEPTOR 4 AS A BASIS OF CYCLOOXYGENASE 2-DEPENDENT ATHEROSCLEROTIC PLAQUE INSTABILITY IN HUMANS.
2006-01-01 A., Iezzi; Fazia, Maria Luigia; Cuccurullo, Chiara; D., DE CESARE; Ucchino, Sante; F., Spigonardo; Bucci, Marco; Cuccurullo, Franco; Mezzetti, Andrea; Cipollone, Francesco
HUR protein contributes to modulation of angiotensin ii type 1 receptor expression in human atherosclerotic plaque.
2006-01-01 Cuccurullo, Chiara; Fazia, Ml; Iezzi, A; DE CESARE, D; Ucchino, Sante; Spigonardo, F; Bucci, Marco; Cuccurullo, Franco; Mezzetti, Andrea; Cipollone, Francesco
HuR protein as potential modulator of angiotensin II type 1 receptor expression in human atherosclerotic plaque.
2006-01-01 Cuccurullo, Chiara; Fazia, Maria Luigia; A., Iezzi; D., DE CESARE; Ucchino, Sante; F., Spigonardo; Bucci, Marco; Cuccurullo, Franco; Mezzetti, Andrea; Cipollone, Francesco
Ipertensione arteriosa ed algosensibilità muscolare
2008-01-01 Tafuri, Emmanuele; Lerza, Rosanna; Bucci, Marco; Di Fabio, S.; Affaitati, GIANNA PIA; Fabrizio, Alessandra; Savini, Antonella; Mezzetti, Andrea; Giamberardino, Maria Adele
Angiotensin II Blockade and Total Cardiovascular Risk. Beyond Blood Pressure Reduction.
2008-01-01 Cipollone, Francesco; DI FABIO, Sara; Bucci, Marco; Cicolini, G; Mezzetti, Andrea
Cyclooxygenase and prostaglandin synthases in atherosclerosis: Recent insights and future perspectives
2008-01-01 Cipollone, Francesco; Cicolini, Giancarlo; Bucci, Marco
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Total triterpenic fraction of Centella asiatica in chronic venous insufficiency and in high-perfusion microangiopathy. | 2001 | Incandela, L; Cesarone, Mr; Cacchio, Marisa Adriana; De Sanctis, Mt; Santavenere, C; D'Auro, Mg; Bucci, Marco; Belcaro, Giovanni | |
| Flight microangiopathy in medium- to long-distance flights: prevention of edema and microcirculation alterations with total triterpenic fraction of Centella asiatica. | 2001 | Cesarone, Mr; Incandela, L; De Sanctis, Mt; Belcaro, Giovanni; Geroulakos, G; Griffin, M; Lennox, A; Di Renzo, Ad; Cacchio, Marisa Adriana; Bucci, Marco | |
| Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of Centella Asiatica: a clinical prospective randomized trial with a microcirculatory model. | 2001 | Cesarone, Mr; Incandela, L; De Sanctis, Mt; Belcaro, Giovanni; Bavera, P; Bucci, Marco; Ippolito, E. | |
| Microcirculatory effects of total triterpenic fraction of Centella asiatica in chronic venous hypertension: measurement by laser Doppler, TcPO2-CO2, and leg volumetry. | 2001 | Cesarone, Mr; Belcaro, G; Rulo, A; Griffin, M; Ricci, A; Ippolito, E; DE SANCTIS, Mt; Incandela, L; Bavera, P; Cacchio, M; Bucci, Marco | |
| Total triterpenic fraction of Centella asiatica in the treatment of venous hypertension: a clinical, prospective, randomized trial using a combined microcirculatory model. | 2001 | Incandela, L; Belcaro, Giovanni; De Sanctis, Mt; Cesarone, Mr; Griffin, M; Ippolito, E; Bucci, Marco; Cacchio, Marisa Adriana | |
| Treatment of Diabetic Microangiopathy and Edema with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled Randomized Study. | 2001 | Incandela, L; Belcaro, G; Cesarone, Mr; De Sanctis, Mt; Nargi, E; Patricelli, P; Bucci, Marco | |
| Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10 year follow-up study (the CAFES-CAVE Study). | 2001 | Belcaro, G; Nicolaides, An; Ramaswami, G; Cesarone, Mr; DE SANCTIS, Mt; Incandela, L; Ferrari, Pg; Geroulakos, G; Barsotti, A; Griffin, M; Dhanjil, S; Bucci, Marco | |
| HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial. | 2002 | Incandela, L; Belcaro, G; Renton, S; Desanctis, Mt; Cesarone, Mr; Bavera, P; Ippolito, E; Bucci, Marco; Griffin, M; Geroulakos, G; Dugall, M; Golden, G; Acerbi, G. | |
| Treatment of intermittent claudication with pentoxifylline: A 12-month, randomized trial: Walking distance and microcirculation | 2002 | De Sanctis, M. T.; Cesarone, M. R.; Belcaro, Giovanni; Nicolaides, A. N.; Griffin, M.; Incandela, L.; Bucci, Marco; Geroulakos, G.; Ramaswami, G.; Vasdekis, S.; Agus, G.; Bavera, P.; Ippolito, E. | |
| Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial. | 2002 | DE SANCTIS, Mt; Cesarone, Mr; Belcaro, G; Nicolaides, An; Griffin, M; Incandela, L; Bucci, Marco; Geroulakos, G; Ramaswami, G; Vasdekis, S; Agus, G; Bavera, P; Ippolito, E. | |
| Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. | 2003 | Cipollone, Francesco; Ferri, C; Desideri, G; Paloscia, L; Materazzo, G; Mascellanti, M; Fazia, Maria Luigia; Iezzi, Annalisa; Cuccurullo, Chiara; Pini, Barbara; Bucci, Marco; Santucci, A; Cuccurullo, Franco; Mezzetti, Andrea | |
| Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteases activity | 2004 | Cipollone, Francesco; Fazia, Maria Luigia; Iezzi, Annalisa; Pini, Barbara; Cuccurullo, Chiara; Zucchelli, Mirco; DE CESARE, Domenico; Ucchino, Sante; Spigonardo, F; DE LUCA, MARIA LUIGIA; Muraro, Raffaella; Bei, R; Bucci, Marco; Cuccurullo, Franco; Mezzetti, Andrea | |
| Association between 5-lipoxygenase expression and plaque instability in humans. | 2005 | Cipollone, Francesco; Mezzetti, Andrea; Fazia, Maria Luigia; Cuccurullo, Chiara; Chiarelli, Francesco; Ucchino, Sante; Spigonardo, F; Bucci, Marco; Cuccurullo, Franco; Prescott, Sm; Stafforini, Dm; Iezzi, Annalisa | |
| Reduced TIA-1 expression in vulnerable atherosclerotic plaques as a basis of cyclooxygenase-2-dependent plaque instability in humans. | 2005 | Cipollone, Francesco; Fazia, Maria Luigia; A., Iezzi; Cuccurullo, Chiara; Ucchino, Sante; F., Spigonardo; Bucci, Marco; Mezzetti, Andrea | |
| OVEREXPRESSION OF TOLL LIKE RECEPTOR 4 AS A BASIS OF CYCLOOXYGENASE 2-DEPENDENT ATHEROSCLEROTIC PLAQUE INSTABILITY IN HUMANS. | 2006 | A., Iezzi; Fazia, Maria Luigia; Cuccurullo, Chiara; D., DE CESARE; Ucchino, Sante; F., Spigonardo; Bucci, Marco; Cuccurullo, Franco; Mezzetti, Andrea; Cipollone, Francesco | |
| HUR protein contributes to modulation of angiotensin ii type 1 receptor expression in human atherosclerotic plaque. | 2006 | Cuccurullo, Chiara; Fazia, Ml; Iezzi, A; DE CESARE, D; Ucchino, Sante; Spigonardo, F; Bucci, Marco; Cuccurullo, Franco; Mezzetti, Andrea; Cipollone, Francesco | |
| HuR protein as potential modulator of angiotensin II type 1 receptor expression in human atherosclerotic plaque. | 2006 | Cuccurullo, Chiara; Fazia, Maria Luigia; A., Iezzi; D., DE CESARE; Ucchino, Sante; F., Spigonardo; Bucci, Marco; Cuccurullo, Franco; Mezzetti, Andrea; Cipollone, Francesco | |
| Ipertensione arteriosa ed algosensibilità muscolare | 2008 | Tafuri, Emmanuele; Lerza, Rosanna; Bucci, Marco; Di Fabio, S.; Affaitati, GIANNA PIA; Fabrizio, Alessandra; Savini, Antonella; Mezzetti, Andrea; Giamberardino, Maria Adele | |
| Angiotensin II Blockade and Total Cardiovascular Risk. Beyond Blood Pressure Reduction. | 2008 | Cipollone, Francesco; DI FABIO, Sara; Bucci, Marco; Cicolini, G; Mezzetti, Andrea | |
| Cyclooxygenase and prostaglandin synthases in atherosclerosis: Recent insights and future perspectives | 2008 | Cipollone, Francesco; Cicolini, Giancarlo; Bucci, Marco |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile